Loading Please wait, logging in.
Join ALFA Member Login RSS Feed
Tagline Image
Bookmark and Share  

Antipsychotics Beneficial For Some Individuals With Alzheimer’s

A new study suggests that people with Alzheimer’s on the drug risperidone, an antipsychotic drug often prescribed as the brand name Risperdal, may be better off continuing to take the drug if they have not experienced negative side effects.

Because of the potential side effects, risperidone is only recommended to be prescribed for three to six months. After that point, a written explanation is required to continue the drug. A study, published in the New England Journal of Medicine and funded by the National Institutes of Health, investigated the effects of discontinuing the medication among individuals who had seen improvements as a result of the drug. Researchers prescribed risperidone to individuals with Alzheimer’s disease who showed signs of agitation and aggression. After 16 weeks, researchers put half of the individuals who did well on the drug on a placebo. The other half continued the treatment. The study found that those on the placebo were twice as likely to have their symptoms return. The rate of side effects and death were equal among the two groups.

Researchers warned that antipsychotics can carry the risk of serious side effects and should not be used on all individuals with Alzheimer’s disease, but discontinuing medication that has achieved benefits is not always the right choice. "One must be cautious about discontinuing the medication,” said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City.  “If a person does well on it and there are not too many side effects, maybe they should stay on it for a while and be monitored closely."

For more information, read the article: Some With Alzheimer's Better Off Staying on Antipsychotics: Study  Or, read the full study: Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.

 
Suggested Articles:

11/18/2014
Ageism, Elder Abuse, Health and Wellness, Health Care, Managed Risk
It’s now open season for people seeking to switch health coverage plans and that means watch out for scams, says the Federal Trade Commission. The ...
11/10/2014
Business Planning, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Partnerships, Strategy
Senior living residents are encouraging providers to put increasing emphasis on brain health initiatives, according to Senior Living Executive. Senior...
11/10/2014
End of Life, Managed Risk
The discussion about planning for end-of-life care or care for advanced illness is regaining traction among the health policy community and the public...
11/10/2014
Although concerns over Ebola are abating in the United States, the Centers for Disease Control and Prevention continues to disseminate information abo...
11/10/2014
Best of the Best Awards, cheatsheet, Life Safety, Managed Risk, Security, Technology Infrastructure
Status Solutions of Charlottesville, Va., won in the Information Technology category in 2014 for its SARA eMessenger mobile, or Situational Awareness ...
11/4/2014
Federal Agency Activity, Medication Technology & Informatics, Memory Care Best Practices and Research, Memory Care Education
The National Institute on Aging’s Office of Special Populations is making efforts to recruit African-Americans for clinical trial recruitment and post...
11/4/2014
Choice, End of Life, Facts and Figures, Managed Risk, Reports
Half of older adults who sustain injuries so severe that they could die in the hospital or not be able to function independently are not asked in the ...
11/4/2014
Allied Member, Best of the Best Awards, Clinical Quality and Quality Care Delivery, Health and Wellness, President's Council, Quality of Life, Wellness Program
Fox Rehabilitation of Cherry Hill, N.J., garnered a Program to Spotlight award in 2014 for its Fox Optimal Living Program. Truly good health is as ...
11/4/2014
End of Life, Facts and Figures, Memory Care Best Practices and Research, Memory Care Education, Reports
Researchers have developed a blood test that could diagnose early onset Alzheimer’s disease. The University of Melbourne researchers previously identi...
10/30/2014
The Alzheimer’s Association of America is hosting National Memory Screening Day, November 18. During the event, healthcare professionals are providing...
   
10/23/2012


Additional Resources